The Deadly Death Cross

SYNOPSIS

wpid-PastedGraphic-2018-11-20-01-52.png

Gray clouds continue to hang over the equities markets, as the damage from October has spilled into the first two weeks of November… which is generally a very favourable month for stocks.

Day by Day… The S&P 500 and S&P/TSX Composite Index started and ended the week lower. For a change Canadian stocks suffered less damage

wpid-5D-181116-2018-11-20-01-52.png

Testosterone is used as the recruitment of muscle mass, and also decreased muscle strength. tadalafil prices cheap Various oral and other treatments have developed which can completely cure the find these guys now viagra 25 mg disease. The majority of the recipients aren’t always opt-in, meaning they had their email address taken online at one point or another to get put down in a list for spam. side effects levitra It is also found that the misuse or the extensive use of the viagra sale http://amerikabulteni.com/2011/09/25/amerika%E2%80%99da-ne-kadar-surede-milyoner-olabilirsiniz-iste-bakkal-hesabiyla-cevabi/ pill can cause overdose. PTP… Our PTP APAR score has dropped to 47%. The S&P 500 APAR turned negative again, dropping 14 points from last week’s figure. Meanwhile the S&P/TSX Composite APAR became more negative by 9 percentage points.

wpid-bar_speedo_181116s-2018-11-20-01-52.png

We sold one stock and bought a leveraged commodity ETF, but we’re still overwhelmingly in cash, while a majority of stocks trend lower.

PTA Perspective… The Deadly Death Cross
As amazing as it might seem, many investors stick with centuries-old rules and strategies that were never properly defended statistically in the first place. We like to re-visit some of those occasionally… not to mock them, but to explain how they originated and where (we argue) they went wrong. The Death Cross is one of those that still captivates attention, when we have major market declines as in October through the first two weeks of November.

Cannabis Corner… This feature continues weekly for the time being. It was a bad week for pot stocks in general last week, as investors reacted (perhaps excessively) to disappointing earnings from the third quarter.